Burney Company’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,070
| Closed | -$234K | – | 581 |
|
|
2023
Q1 | $234K | Hold |
4,070
| – | – | 0.01% | 518 |
|
|
2022
Q4 | $228K | Buy |
+4,070
| New | +$207K | 0.01% | 509 |
|
|
2022
Q3 | – | Sell |
-4,070
| Closed | -$220K | – | 555 |
|
|
2022
Q2 | $220K | Buy |
4,070
+40
| +1% | +$2.4K | 0.01% | 512 |
|
|
2022
Q1 | $259K | Hold |
4,030
| – | – | 0.01% | 518 |
|
|
2021
Q4 | $270K | Hold |
4,030
| – | – | 0.01% | 513 |
|
|
2021
Q3 | $276K | Hold |
4,030
| – | – | 0.01% | 493 |
|
|
2021
Q2 | $275K | Sell |
4,030
-80
| -2% | -$5.66K | 0.01% | 514 |
|
|
2021
Q1 | $284K | Hold |
4,110
| – | – | 0.01% | 486 |
|
|
2020
Q4 | $267K | Buy |
+4,110
| New | +$221K | 0.01% | 457 |
|
|
2020
Q1 | – | Sell |
-4,150
| Closed | -$242K | – | 451 |
|
|
2019
Q4 | $242K | Sell |
4,150
-300
| -7% | -$17.9K | 0.01% | 428 |
|
|
2019
Q3 | $267K | Buy |
4,450
+40
| +0.9% | +$2.38K | 0.02% | 391 |
|
|
2019
Q2 | $246K | Hold |
4,410
| – | – | 0.01% | 409 |
|
|
2019
Q1 | $246K | Buy |
+4,410
| New | +$225K | 0.02% | 407 |
|
|
2018
Q4 | – | Sell |
-4,660
| Closed | -$307K | – | 438 |
|
|
2018
Q3 | $307K | Sell |
4,660
-190
| -4% | -$11.8K | 0.02% | 375 |
|
|
2018
Q2 | $312K | Sell |
4,850
-260
| -5% | -$16.1K | 0.02% | 365 |
|
|
2018
Q1 | $283K | Sell |
5,110
-740
| -13% | -$38.8K | 0.02% | 344 |
|
|
2017
Q4 | $280K | Buy |
5,850
+40
| +0.7% | +$1.96K | 0.02% | 355 |
|
|
2017
Q3 | $290K | Hold |
5,810
| – | – | 0.02% | 327 |
|
|
2017
Q2 | $313K | Hold |
5,810
| – | – | 0.02% | 323 |
|
|
2017
Q1 | $245K | Hold |
5,810
| – | – | 0.02% | 341 |
|
|
2016
Q4 | $249K | Sell |
5,810
-700
| -11% | -$28.5K | 0.02% | 340 |
|
|
2016
Q3 | $277K | Sell |
6,510
-260
| -4% | -$10.9K | 0.02% | 323 |
|
|
2016
Q2 | $270K | Buy |
6,770
+380
| +6% | +$13.7K | 0.02% | 322 |
|
|
2016
Q1 | $215K | Hold |
6,390
| – | – | 0.02% | 364 |
|
|
2015
Q4 | $216K | Buy |
+6,390
| New | +$200K | 0.02% | 353 |
|
|
2015
Q3 | – | Sell |
-7,816
| Closed | -$215K | – | 379 |
|
|
2015
Q2 | $215K | Sell |
7,816
-2,919
| -27% | -$77.8K | 0.01% | 376 |
|
|
2015
Q1 | $271K | Buy |
+10,735
| New | +$254K | 0.02% | 353 |
|
|
2014
Q3 | – | Sell |
-25,240
| Closed | -$486K | – | 405 |
|
|
2014
Q2 | $486K | Sell |
25,240
-11,232
| -31% | -$209K | 0.04% | 278 |
|
|
2014
Q1 | $686K | Sell |
36,472
-1,534
| -4% | -$29.6K | 0.06% | 242 |
|
|
2013
Q4 | $741K | Sell |
38,006
-746
| -2% | -$13.7K | 0.07% | 236 |
|
|
2013
Q3 | $638K | Hold |
38,752
| – | – | 0.07% | 241 |
|
|
2013
Q2 | $580K | Buy |
+38,752
| New | +$568K | 0.07% | 238 |
|
Other funds holding IART
CIP
CB
Burney Company's IART Position: Q2 2023 in Review
Burney Company sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 4,070 shares — an estimated $234K sold.
Burney Company first reported a position in IART in Q2 2013 and held it in 32 quarters. The position peaked at $741K in Q4 2013. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.
- Burney Company reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
- Burney Company sold 4,070 Integra LifeSciences shares in Q2 2023, an estimated $234K.
- Burney Company first reported a position in Integra LifeSciences in Q2 2013 and held it in 32 quarters.
- Burney Company's Integra LifeSciences position peaked at $741K in Q4 2013.
- 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.
Based on Burney Company's 13F filing for Q2 2023, filed 9 Aug 2023.